학술논문
BRILLIANCE: A Phase 1/2 Single Ascending Dose Study of EDIT-101, an in vivo CRISPR Gene Editing Therapy, in CEP290-Related Retinal Degeneration
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15577422